May 10, 2024 10 min watch ...

Su1570 IMPACT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS CIRRHOSIS ON INPATIENT OUTCOMES AFTER ACUTE MYOCARDIAL INFARCTION

Su1567 THE MOLECULAR BASIS OF THYROID HORMONE RESCUE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN MICE

EP19 IMPROVING TRIAGE AND CARE FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AT A VA PRIMARY CARE CLINIC

Sa1526 CATENIBACTERIUM MITSUOKAI PROMOTES TUMOR IMMUNOSUPPRESSION THROUGH METABOLIC REPROGRAMMING OF PMN-MDSC IN HEPATOCELLULAR CARCINOMA

Tu1603 COMBINATION SLEEVE GASTRECTOMY (SG) WITH LIVER TRANSPLANTATION: SHOULD IT BE THE STANDARD PRACTICE IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOSIS ...

Su1566 DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY

Su1609 SEVERE OBESITY IS ASSOCIATED WITH WORSE OUTCOMES THAN LEAN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A POPULATION-BASED COHORT STUDY ...

Mo1631 DISTINCT PATTERNS OF STELLATE CELL PHENOTYPIC MODULATION IN ALCOHOLIC AND METABOLIC DYSFUNCTION-ASSOCIATED CIRRHOSIS

Su1562 RELEVANCE OF MAST CELLS IN THE ADVANCED STAGES OF METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE